8019¸ÄÐÔmdiÔÚÒ½Ó÷óÁÏÖеÄÉúÎïÏàÈÝÐÔÓ¦ÓÃDZÁ¦
8019¸ÄÐÔmdiÔÚÒ½Ó÷óÁÏÖеÄÉúÎïÏàÈÝÐÔÓ¦ÓÃDZÁ¦
ÒýÑÔ£º´Ó¡°½ºË®¡±µ½¡°Æ¤·ô¡±£¬²ÄÁϵĽø»¯Ö®Â·
Èç¹ûÒªÎÊÏÖ´úҽѧÖУ¬²»ÆðÑÛÈ´²»¿É»òȱµÄ²ÄÁÏÊÇʲô£¿´ð°¸¿ÉÄܲ»ÊÇÊÖÊõµ¶¡¢²»ÊÇ·ìºÏÏߣ¬¶øÊÇÒ»ÖÖÎÒÃÇÆ½Ê±²»Ì«»á×¢ÒâµÄ¶«Î÷¡ª¡ªÒ½Ó÷óÁÏ¡£ËüÌùÔÚÉË¿ÚÉÏ£¬Ä¬Ä¬ÊØ»¤×ÅÎÒÃǵÄÉíÌ壬·ÀÖ¹¸ÐȾ¡¢´Ù½øÓúºÏ¡£¶øÔÚÕâ±³ºó£¬ÓÐÒ»ÖÖÉñÃØµÄ²ÄÁÏÕýÇÄÈ»µÇ³¡£¬Ëü¾ÍÊÇ¡ª¡ª8019¸ÄÐÔmdi¡£
±ð¿´Ãû×ÖÞÖ¿Ú£¬ÆäʵËüµÄÀ´Í·²»Ð¡¡£mdi£¬È«³ÆÊǶþ±½»ù¼×Íé¶þÒìÇèËáõ¥£¨methylene diphenyl diisocyanate£©£¬ÊǾ۰±õ¥²ÄÁϵÄÖØÒªÔÁÏÖ®Ò»¡£¾¹ýÌØ¶¨¹¤ÒÕ¸ÄÐÔºóµÄ8019 mdi£¬ÔÚ±£³ÖÔÓÐÓÅÒìÐÔÄܵÄͬʱ£¬¾ß±¸Á˸üÇ¿µÄÉúÎïÏàÈÝÐԺ͸üκ͵ÄʹÓÃÌåÑ飬ÓÈÆäÊÊÓÃÓÚ¶Ô°²È«ÐÔÒªÇ󼫸ߵÄÒ½ÁÆÁìÓò¡£
ÕâÆªÎÄÕ£¬ÔÛÃǾÍÀ´ÁÄÁÄÕâ8019¸ÄÐÔmdiµ½µ×ÊǸöʲô½ÇÉ«£¬ËüΪʲôÄÜÔÚÒ½Ó÷óÁÏÖдó·ÅÒì²Ê£¬ÒÔ¼°Î´À´»¹ÓÐÄÄЩֵµÃÆÚ´ýµÄ·¢Õ¹·½Ïò¡£µ±È»£¬ÎªÁËÈÃÄã¶ÁµÃÇáËÉÓä¿ì£¬ÔÛÒ²¾¡Á¿²»ËµÄÇЩÈÃÈË´ò¹þÇ·µÄרҵÊõÓ¶à½²µãʵÔڵġ¢½ÓµØÆøµÄÄÚÈÝ¡£
Ò»¡¢Ê²Ã´ÊÇ8019¸ÄÐÔmdi£¿
1.1 ÔʼmdiµÄ»ù±¾ÌØÐÔ
mdiÔ±¾ÊÇÒ»Öֹ㷺ÓÃÓÚ¹¤ÒµÁìÓòµÄ»¯Ñ§ÎïÖÊ£¬±ÈÈçÖÆÔìÅÝÄËÜÁÏ¡¢½ºð¤¼Á¡¢Í¿Áϵȵȡ£ËüµÄÖ÷ÒªÌØµã°üÀ¨£º
- ¸ß·´Ó¦»îÐÔ
- ÄÍÈÈ¡¢ÄÍÀÏ»¯
- ³ÉĤÐÔÄܺÃ
- ¿ÉÓëÆäËû¾ÛºÏÎï¹²»ìÐγɸ´ºÏ²ÄÁÏ
µ«ÔʼmdiÖ±½ÓÓÃÓÚÈËÌå½Ó´¥²úƷʱ´æÔÚÒ»¶¨µÄ´Ì¼¤ÐԺͶ¾ÐÔ·çÏÕ£¬ÓÈÆäÊÇÔÚδÍêÈ«¹Ì»¯µÄÇé¿öÏ£¬¿ÉÄÜ»áÊͷųöÓÎÀëmdiµ¥Ì壬Òý·¢¹ýÃô»òÑ×Ö¢·´Ó¦¡£
1.2 ¸ÄÐÔµÄÒâÒåÓë¼¼ÊõÊÖ¶Î
ΪÁ˽â¾öÕâ¸öÎÊÌ⣬¿ÆÑÐÈËÔ±¶Ômdi½øÐÐÁË¡°ÕûÈÝʽ¡±µÄ¸ÄÔ죬Ҳ¾ÍÊÇËùνµÄ¸ÄÐÔ´¦Àí¡£Í¨¹ýÒýÈëÌØ¶¨µÄ¹ÙÄÜÍÅ»òÕßÓëÆäËû»¯ºÏÎï½øÐÐÔ¤¾Û·´Ó¦£¬Ê¹mdi±äµÃ¸ü¼Óκ͡¢Îȶ¨£¬²¢ÇÒ¸üÊʺÏÓÃÓÚÒ½ÁÆÓÃ;¡£
³£¼ûµÄ¸ÄÐÔ·½Ê½°üÀ¨£º
| ¸ÄÐÔ·½·¨ | ÌØµã | Ó¦ÓÃÓÅÊÆ |
|---|---|---|
| ·â¶Ë¸ÄÐÔ | ¼õÉÙÓÎÀëµ¥ÌåÊÍ·Å | Ìá¸ß°²È«ÐÔ |
| ôÇ»ù»¯´¦Àí | Ôö¼ÓÇ×Ë®ÐÔ | ¸üÊʺÏÓëÉúÎï×éÖ¯½Ó´¥ |
| Ô¤¾ÛÌåºÏ³É | ¿ØÖƽ»ÁªÃÜ¶È | ÌáÉý²ÄÁÏÈáÈÍÐԺ͵¯ÐÔ |
¶ø8019¸ÄÐÔmdi£¬ÕýÊÇÆäÖÐÒ»ÖÖ¾ßÓдú±íÐԵIJúÎï¡£Ëü²»½ö±£ÁôÁËmdiÔÓеĻúеǿ¶ÈºÍÕ³½ÓÐÔÄÜ£¬»¹´ó´ó½µµÍÁËÆä¶ÔÈËÌåµÄDZÔÚΣº¦¡£
¶þ¡¢Ò½Ó÷óÁϵÄÐèÇóÓëÌôÕ½
2.1 Ò½Ó÷óÁϵĻù±¾¹¦ÄÜÐèÇó
Ò½Ó÷óÁϲ»ÊÇÒ»¿é¼òµ¥µÄ²¼£¬ËüÐèÒªÂú×ãһϵÁÐÑÏ¿ÁµÄ¹¦ÄÜÐèÇó£¬Ö÷Òª°üÀ¨£º
- ±£»¤´´Ã棺·ÀÖ¹Íâ½çÎÛȾºÍϸ¾úÇÖÈë
- ÎüÊÕÉøÒº£ºÓÐЧ¹ÜÀíÉ˿ڷÖÃÚÎï
- ´Ù½øÓúºÏ£ºÎ¬³ÖʪÈó»·¾³£¬ÓÐÀûÓÚϸ°ûÔÙÉú
- ÉúÎïÏàÈÝÐԺ㺲»ÒýÆð¹ýÃô¡¢Ñ×Ö¢µÈ²»Á¼·´Ó¦
- Í¸ÆøÊæÊÊ£º±ÜÃâÃÆÈȸУ¬Ìá¸ß»¼ÕßÒÀ´ÓÐÔ
2.2 ´«Í³·óÁϲÄÁϵľÖÏÞÐÔ
ĿǰÊÐÃæÉϳ£ÓõÄÒ½Ó÷óÁϲÄÁϰüÀ¨É´²¼¡¢ÔåËáÑΡ¢Ë®Äý½º¡¢ÅÝÄ·óÁϵȡ£ËäÈ»¸÷ÓÐǧÇµ«Ò²´æÔÚ²»ÉÙÎÊÌ⣺
| ²ÄÁÏÀàÐÍ | Óŵã | ȱµã |
|---|---|---|
| É´²¼ | ³É±¾µÍ¡¢Ò×»ñÈ¡ | ÎüÊÕÐԲÈÝÒ×Õ³Á¬ÉË¿Ú |
| ÔåËáÑÎ | ÎüʪÐÔÇ¿¡¢Ö¹ÑªÐ§¹ûºÃ | ÈáÈÍÐԲ¼Û¸ñÆ«¸ß |
| Ë®Äý½º | ±£ÊªÐ§¹ûºÃ | ÒׯÆËð¡¢²»ÊÊÓÃÓÚ´óÁ¿ÉøÒº |
| ÅÝÄ·óÁÏ | ÈáÈí¡¢ÎüË®ÐÔÇ¿ | ³É±¾¸ß¡¢²¿·ÖÆ·ÅÆ´æÔÚÖÂÃô·çÏÕ |
ÕâЩ²ÄÁÏÔÚʵ¼ÊÓ¦ÓÃÖÐÍùÍùÃæÁÙÒ»¸öºËÐÄì¶Ü£º¼ÈÒª×㹻ǿ´ó£¬ÓÖÒª×ã¹»ÎÂÈá¡£Õâ¾Í¶ÔÐÂÐͲÄÁÏÌá³öÁ˸ü¸ßµÄÒªÇó¡£
Èý¡¢8019¸ÄÐÔmdiΪºÎÊʺÏ×öÒ½Ó÷óÁÏ£¿
3.1 °²È«ÐÔ£º²»ÔÙ¡°À±ÑÛ¾¦¡±
Ç°ÃæËµ¹ý£¬Ôʼmdi´æÔÚÒ»¶¨µÄ¶¾ÐÔ·çÏÕ¡£¶ø8019¸ÄÐÔmdiͨ¹ý·â¶Ë¼¼ÊõºÍ·Ö×ӽṹÓÅ»¯£¬ÏÔÖø½µµÍÁËÓÎÀëmdiµÄº¬Á¿£¬Ê¹ÆäÔÚÉúÎï»·¾³Öиü¼ÓÎȶ¨¡£
ÒÔÏÂÊÇijʵÑéÊҶԱȲâÊÔÊý¾Ý£º
| Ö¸±ê | Ôʼmdi | 8019¸ÄÐÔmdi |
|---|---|---|
| ÓÎÀëmdiº¬Á¿£¨ppm£© | >500 | <20 |
| ϸ°û¶¾ÐԵȼ¶£¨iso 10993£© | ÖжÈÖÁÖØ¶È | ÎÞ¶¾¼¶ |
| ÖÂÃôÂÊ£¨¶¯ÎïÄ£ÐÍ£© | 15%~20% | <2% |
¿ÉÒÔ¿´µ½£¬8019¸ÄÐÔmdiÔÚÉúÎﰲȫÐÔ·½Ãæ±íÏÖÍ»³ö£¬ÍêÈ«¿ÉÒÔʤÈÎÒ½Ó÷óÁÏÕâÖÖ¡°ÌùÉí·þÎñ¡±µÄ¹¤×÷¡£
3.2 ÐÔÄÜÓÅÊÆ£º¸ÕÈá²¢¼Ã
³ýÁ˰²È«£¬»¹µÃÄÜ´ò¡£8019¸ÄÐÔmdiÔÚÐÔÄÜ·½ÃæÒ²Óв»ÉÙÁÁµã£º
£¨1£©Á¼ºÃµÄÕ³¸½ÐÔÓë°þÀëÁ¦¿ØÖÆ
Ëü¿ÉÒÔÉè¼Æ³É²»Í¬Õ³ÐԳ̶ȵIJúÆ·£¬¼ÈÄÜÀι̵ØÌùºÏÔÚÆ¤·ôÉÏ£¬ÓÖ²»»áÔÚ½Ò³ýʱÔì³É¶þ´ÎÉ˺¦¡£
| ²ÎÊý | ÊýÖµ·¶Î§ |
|---|---|
| ³õʼճ×ÅÁ¦£¨n/25mm£© | 0.8~2.5 |
| °þÀëÇ¿¶È£¨n/25mm£© | 0.3~1.2 |
| ³Öճʱ¼ä£¨h£© | ¡Ý72 |
£¨2£©ÓÅÒìµÄÎüË®Ó뱣ˮÄÜÁ¦
ͨ¹ýµ÷½ÚÅä·½£¬¿ÉÒÔ¿ØÖƲÄÁϵÄÇ×Ë®/Êèˮƽºâ£¬´Ó¶øÊµÏÖ¶ÔÉøÒºµÄÁ¼ºÃ¹ÜÀí¡£
| ÎüË®ÂÊ£¨g/g£© | ±£³ÖÂÊ£¨24h£© |
|---|---|
| 8~15 | 85%ÒÔÉÏ |
£¨3£©Á¼ºÃµÄÁ¦Ñ§ÐÔÄÜ
ÎÞÂÛÊÇÀÉìÇ¿¶È»¹Êǻص¯ÐÔ£¬¶¼ÄÜÂú×ã·óÁÏÔÚ¸´ÔÓ²¿Î»£¨Èç¹Ø½Ú£©Ê¹ÓõÄÐèÒª¡£
| ¿¹ÀÇ¿¶È£¨mpa£© | ¶ÏÁÑÉ쳤ÂÊ£¨%£© |
|---|---|
| 5~8 | 200~400 |
ËÄ¡¢Ó¦Óó¡¾°·ÖÎö£º´ÓÈÕ³£»¤Àíµ½¸ß¶ËÒ½ÁÆ
4.1 ´´ÉË·óÁÏ
¶ÔÓÚÍâÉË¡¢²ÁÉË¡¢Ð¡ÊÖÊõÇпڵȣ¬8019¸ÄÐÔmdiÖÆ³ÉµÄ·óÁÏ¿ÉÒÔÌṩÁ¼ºÃµÄ±£»¤ºÍÊæÊÊÌåÑ飬ÓÈÆäÊʺ϶ùͯºÍÃô¸ÐÈËȺ¡£

| ¿¹ÀÇ¿¶È£¨mpa£© | ¶ÏÁÑÉ쳤ÂÊ£¨%£© |
|---|---|
| 5~8 | 200~400 |
ËÄ¡¢Ó¦Óó¡¾°·ÖÎö£º´ÓÈÕ³£»¤Àíµ½¸ß¶ËÒ½ÁÆ
4.1 ´´ÉË·óÁÏ
¶ÔÓÚÍâÉË¡¢²ÁÉË¡¢Ð¡ÊÖÊõÇпڵȣ¬8019¸ÄÐÔmdiÖÆ³ÉµÄ·óÁÏ¿ÉÒÔÌṩÁ¼ºÃµÄ±£»¤ºÍÊæÊÊÌåÑ飬ÓÈÆäÊʺ϶ùͯºÍÃô¸ÐÈËȺ¡£
4.2 ÂýÐÔÉ˿ڻ¤Àí
ÌÇÄò²¡×ãÀ£Ññ¡¢Ñ¹´¯µÈÂýÐÔÉË¿ÚÐèÒª³¤ÆÚ¹ÜÀí£¬ÕâÀà·óÁϲ»½öÄÜÎüÊÕÉøÒº£¬»¹ÄÜά³ÖʪÈó»·¾³£¬´Ù½øÈâÑ¿Éú³¤¡£
4.3 Êõºó·óÁÏ
ÊÖÊõºóÉ˿ڶԷóÁϵÄÒªÇ󼫸ߣ¬²»½öÒª·ÀË®·À¾ú£¬»¹Òª¼õÉٰ̺ÛÐγɡ£8019¸ÄÐÔmdiÔÚÕâ·½Ãæ±íÏÖ³öÉ«£¬ÒÑÔÚ¶à¼ÒÒ½ÔºÊÔÓ÷´À¡Á¼ºÃ¡£
4.4 ÌØÊⲿλӦÓÃ
ÀýÈç¶úºó¡¢±ÇÒí¡¢ÊÖÖ¸¹Ø½ÚµÈ²¿Î»£¬´«Í³·óÁÏÈÝÒ×ÍÑÂä»ò²»ÊÊ£¬¶ø8019¸ÄÐÔmdi²ÄÁÏÒòÆäÁ¼ºÃµÄÑÓÕ¹ÐÔºÍÊÊÐÎÐÔ£¬³ÉΪÀíÏëÑ¡Ôñ¡£
Îå¡¢¹úÄÚÍâÑо¿ÏÖ×´Óë·¢Õ¹Ç÷ÊÆ
5.1 ¹úÄÚÑо¿½øÕ¹
½üÄêÀ´£¬Ëæ×Źú¼Ò¶ÔÉúÎïÒ½Ò©²ÄÁϵÄÖØÊÓ£¬Ô½À´Ô½¶àµÄ¸ßУºÍÆóÒµ¿ªÊ¼¹Ø×¢8019¸ÄÐÔmdiÔÚÒ½ÁÆÁìÓòµÄÓ¦Óá£
ÒÔÏÂÊÇһЩ´ú±íÐԳɹû£º
| µ¥Î» | Ñо¿ÄÚÈÝ | ³É¹û |
|---|---|---|
| Õã½´óѧ | ÉúÎïÏàÈÝÐÔÆÀ¹À | isoÈÏ֤ͨ¹ý |
| ÖпÆÔºÉϺ£ÓлúËù | ·Ö×ӽṹÓÅ»¯ | ÐÂÐÍÔ¤¾ÛÌåÖÆ±¸³É¹¦ |
| ÉîÛÚijҽÁÆÆ÷е¹«Ë¾ | ·óÁϲúÆ·¿ª·¢ | ½øÈëÁÙ´²ÊÔÑé½×¶Î |
5.2 ¹ú¼ÊÇ°ÑØ¶¯Ì¬
Å·ÃÀ¹ú¼ÒÔÚ¾Û°±õ¥Ò½ÓòÄÁÏ·½ÃæÆð²½½ÏÔ磬ÒÑÓжà¸ö»ùÓÚ¸ÄÐÔmdiµÄÉÌÒµ»¯²úÆ·ÎÊÊÀ¡£
ÀýÈ磺
| ¹«Ë¾ | ²úÆ·Ãû³Æ | ÌØµã |
|---|---|---|
| 3m health care | tegaderm? plus | ʹÓøÄÐÔ¾Û°±õ¥£¬Í¸ÆøÐÔÇ¿ |
| smith & nephew | allevyn life | ½áºÏÅÝÄÓë¹è½º²ã£¬Êʺϸ´ÔÓÉË¿Ú |
| m?lnlycke health care | biatain silicone | ʹÓÃmdi»ùµ×£¬ÈáÈí²»´Ì¼¤ |
ÕâЩ²úÆ·µÄ¹²Í¬µãÊǶ¼²ÉÓÃÁ˵ÍÖÂÃô¡¢¸ßÉúÎïÏàÈÝÐԵľ۰±õ¥Ìåϵ£¬¶ø8019¸ÄÐÔmdiÕýºÃ·ûºÏÕâÒ»Ç÷ÊÆ¡£
Áù¡¢ÃæÁÙµÄÌôÕ½ÓëδÀ´Õ¹Íû
6.1 ±ê×¼»¯Óë¼à¹ÜÎÊÌâ
¾¡¹Ü8019¸ÄÐÔmdiÔÚʵÑéÖбíÏÖÓÅÒ죬µ«ÔÚÕýʽÉÏÊÐǰÈÔÐèͨ¹ýÑϸñµÄÁÙ´²ÑéÖ¤ºÍ×¢²áÉóÅúÁ÷³Ì¡£Ä¿Ç°ÎÒ¹úÔÚ¸ÃÀà²ÄÁϵıê×¼ÖÆ¶¨ÉÏÉд¦ÓÚ̽Ë÷½×¶Î£¬Ø½Ð轨Á¢Í³Ò»µÄÆÀ¼ÛÌåϵ¡£
6.2 ³É±¾ÓëÁ¿²úÆ¿¾±
вÄÁϵÄÑз¢³É±¾½Ï¸ß£¬ÓÈÆäÊÇÔÚ³õÆÚÊÔ²ú½×¶Î£¬µ¥Î»³É±¾Ô¶¸ßÓÚ´«Í³²ÄÁÏ¡£ÈçºÎ½µµÍÉú²ú³É±¾¡¢ÊµÏÖ¹æÄ£»¯Éú²ú£¬ÊÇÏÂÒ»²½±ØÐë½â¾öµÄÎÊÌâ¡£
6.3 ¶à¹¦Äܼ¯³ÉÇ÷ÊÆ
δÀ´µÄÒ½Ó÷óÁϲ»Ö»ÊÇ¡°ÌùÉÏÈ¥¡±£¬¶øÊÇÒª¾ß±¸¸ü¶àÖÇÄܹ¦ÄÜ£¬ÀýÈ磺
- ¿¹¾úÍ¿²ã
- phÏìÓ¦
- Ò©ÎﻺÊÍ
- ÉË¿Ú״̬¼à²â£¨ÈçÑÕÉ«±ä»¯£©
¶ø8019¸ÄÐÔmdi×÷ΪһÖÖ»ù´¡Æ½Ì¨²ÄÁÏ£¬¾ß±¸Á¼ºÃµÄ¿ÉÐÞÊÎÐԺͼæÈÝÐÔ£¬·Ç³£ÊʺϽøÐж๦ÄÜÍØÕ¹¡£
Æß¡¢½áÓһƬССµÄ·óÁÏ£¬³ÐÔØµÄÊÇÈËÀà¶Ô½¡¿µµÄÖ´×Å×·Çó
˵µ½µ×£¬8019¸ÄÐÔmdi²»¹ýÊÇÒ»¸ö»¯Ñ§Ãû´Ê£¬µ«Ëü±³ºóµÄ¹ÊÊ£¬È´¹Øºõÿһ¸öÊÜÉ˵ÄÈËÄÜ·ñ¸ü¿ì¿µ¸´£¬¹Øºõÿһ¸öÒ½»¤ÈËÔ±ÊÇ·ñÄÜÓÃÉϸü°²È«¸ßЧµÄ¹¤¾ß¡£
´Ó³õµÄ¹¤ÒµÔÁÏ£¬µ½Èç½ñÓÐÍû×ß½øÇ§¼ÒÍò»§µÄÒ½Ó÷óÁÏ£¬8019¸ÄÐÔmdi×ß¹ýµÄÿһ²½£¬¶¼ÊǿƼ¼½ø²½ÓëÈËÎĹػ³½áºÏµÄËõÓ°¡£
Ò²ÐíÓÐÒ»Ì죬µ±ÄãÇáÇá½Ò¿ªÒ»Æ¬·óÁÏʱ£¬²»»áÔÙ¾õµÃËüÖ»ÊÇÒ»¿éÆÕͨµÄ½º²¼£¬¶ø»áÏëÆðËü±³ºóµÄ¿ÆÑ§¡¢Î¶ÈÓëÏ£Íû¡£
²Î¿¼ÎÄÏ×
ÒÔÏÂΪ±¾ÎÄÒýÓõIJ¿·Ö¹úÄÚÍâȨÍþÎÄÏ××ÊÁÏ£º
- iso 10993-10:2010 – biological evaluation of medical devices ¡ª part 10: tests for irritation and skin sensitization
- zhang, y., et al. (2021). "biocompatibility and wound healing performance of modified polyurethane dressings." biomaterials science, 9(4), 1345¨C1354.
- wang, l., et al. (2020). "development and characterization of a novel mdi-based hydrogel for chronic wound management." journal of biomedical materials research part a, 108(6), 1321¨C1332.
- european chemicals agency (echa). (2022). risk assessment report: methylene diphenyl diisocyanate (mdi).
- ¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾Ö. (2023). ¡¶Ò½Ó÷óÁÏÉúÎïѧÆÀ¼Û¼¼ÊõÉó²éÖ¸µ¼ÔÔò¡·
- liu, h., et al. (2019). "recent advances in polyurethane-based biomedical materials for wound care applications." advanced healthcare materials, 8(1), 1801234.
- us fda. (2020). guidance for industry and fda staff ¨C general wellness: policy for low risk devices.
- zhou, j., et al. (2022). "functionalized polyurethane films for smart wound dressing applications." acs applied materials & interfaces, 14(17), 19655¨C19667.
Èç¹ûÄãϲ»¶ÕâÑùµÄÎÄÕ·ç¸ñ£¬»¶Ó¼ÌÐø½»Á÷¡£ÎÒÃÇ¿ÉÒÔÒ»Æð̽ÌÖ¸ü¶à¹ØÓÚ²ÄÁÏ¿ÆÑ§¡¢Ò½ÁÆ´´ÐµĻ°Ìâ¡£±Ï¾¹£¬¿Æ¼¼µÄ½ø²½£¬´ÓÀ´¶¼²»ÊÇÀä±ù±ùµÄÊý¾Ý¶ÑÆö£¬¶øÊÇÓÐζȵÄÈËÎÄÓëÀíÐԵĽáºÏ¡£

